Immutep Limited - Asset Resilience Ratio

Latest as of December 2025: 17.92%

Immutep Limited (YP1A) has an Asset Resilience Ratio of 17.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check YP1A strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€26.38 Million

≈ $30.84 Million USD Cash + Short-term Investments

Total Assets

€147.20 Million

≈ $172.09 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Immutep Limited's Asset Resilience Ratio has changed over time. See Immutep Limited balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Immutep Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Immutep Limited (YP1A) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€26.38 Million	17.92%
Total Liquid Assets	€26.38 Million	17.92%

Asset Resilience Insights

Good Liquidity Position: Immutep Limited maintains a healthy 17.92% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Immutep Limited Industry Peers by Asset Resilience Ratio

Compare Immutep Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Immutep Limited (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Immutep Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	9.96%	€20.09 Million ≈ $23.48 Million	€201.58 Million ≈ $235.67 Million	--
2023-06-30	0.00%	€0.00 ≈ $0.00	€147.45 Million ≈ $172.38 Million	--

pp = percentage points

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$53.07 Million

€45.39 Million EUR

Market Cap Rank

#21742 Global

#1942 in Germany

Share Price

€0.31

Change (1 day)

+7.69%

52-Week Range

€0.24 - €2.64

All Time High

€4.52